Entering text into the input field will update the search result below

AtriCure Inc. (ATRC) CEO Michael Carrel on Q1 2022 Results - Earnings Call Transcript

May 03, 2022 8:14 PM ETAtriCure, Inc. (ATRC)
SA Transcripts profile picture
SA Transcripts

AtriCure Inc. (NASDAQ:ATRC) Q1 2022 Results Conference Call May 3, 2022 4:30 PM ET

Company Participants

Marissa Bych - Gilmartin Group

Michael Carrel - President, CEO

Angela Wirick - CFO

Conference Call Participants

Robbie Marcus - JPMorgan

Danielle Antalffy - SVB Leerink

John McAulay - Stifel

Sam Eiber - BTIG

David Saxon - Needham

Matthew O'Brien - Piper Sandler

Suraj Kalia - Oppenheimer


Good afternoon, and welcome to AtriCure's First Quarter 2022 Earnings Conference Call. My name is Jeff and I will be your coordinator for call today. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

I would now like to hand the call over to Marissa Bych from the Gilmartin Group for a few introductory comments.

Marissa Bych

Thank you. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call (513) 755-4136 to have one e-mailed to you.

Before we begin today, let me remind you that, the company's remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control, including risks and uncertainties described from time to time in AtriCure's SEC filings.

These statements include, but are not limited to financial expectations and guidance, expectations regarding the potential market opportunity for AtriCure's franchises and growth initiatives, including the adoption of the Hybrid AF procedure and future product approvals, clearances and reimbursement. AtriCure's results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statements.

Additionally, we refer to non-GAAP financial measures, specifically revenue reported on a constant currency basis, adjusted EBITDA and adjusted loss per share. A reconciliation of these non-GAAP financial measures with the most directly comparable GAAP measures is included in our press release, which is available on our

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.